bluebird bio, Inc. License Agreements
22 Contracts & Agreements
- Amendment No. 4 to Patent and Know-How License Agreement No. 07554F33, dated December 16, 2015, by and between the Registrant (formerly known as Genetix, Inc.) and INSERM-TRANSFERT (Filed With SEC on September 13, 2024)
- Amendment No. 3 to Patent and Know-How License Agreement No. 07554F33, dated October 29, 2014, by and between the Registrant (formerly known as Genetix, Inc.) and INSERM-TRANSFERT (Filed With SEC on September 13, 2024)
- Intellectual Property License Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Exclusive Patent License Agreement by and between the Registrant and the National Institutes of Health, dated August 31, 2015 (Filed With SEC on August 9, 2021)
- License Agreement by and between the Registrant and Biogen Idec MA Inc., dated August 13, 2014 (Filed With SEC on August 9, 2021)
- Amended and Restated License Agreement by and between the Registrant and Celgene Corporation, dated February 16, 2016 (Filed With SEC on August 9, 2021)
- Second Amended and Restated License Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment Company LLC, dated May 8, 2020 (Filed With SEC on August 5, 2020)
- License Agreement, dated December 23, 2015, by and between the Registrant and SIRION Biotech GmbH (Filed With SEC on February 21, 2019)
- Amended and Restated License Agreement by and between the Registrant and Celgene Corporation, dated September 28, 2017 (Filed With SEC on November 1, 2017)
- THE National Institutes of Health PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE (Filed With SEC on May 4, 2016)
- LICENSE AGREEMENT (Filed With SEC on May 4, 2016)
- Amended and Restated License Agreement by and between bluebird bio, Inc. and Celgene Corporation and Celgene European Investment Company LLC February 16, 2016 (Filed With SEC on May 4, 2016)
- AMENDMENT N4 TO THE LICENSE AGREEMENT (Filed With SEC on May 6, 2015)
- AMENDMENT N°3 TO THE LICENSE AGREEMENT (Filed With SEC on November 14, 2013)
- LICENSE AGREEMENT BETWEEN RESEARCH DEVELOPMENT FOUNDATION AND BLUEBIRD BIO, INC. (Filed With SEC on May 21, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 21, 2013)
- PATENT AND KNOW-HOW LICENSE AGREEMENT N° 07554F30 (Filed With SEC on May 21, 2013)
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY and INNOGENE PHARMACEUTICALS, INC. PATENT LICENSE AGREEMENT (EXCLUSIVE) -1- (Filed With SEC on May 21, 2013)
- LICENSE AGREEMENT BETWEEN RESEARCH DEVELOPMENT FOUNDATION AND BLUEBIRD BIO, INC. (Filed With SEC on May 14, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 14, 2013)
- PATENT AND KNOW-HOW LICENSE AGREEMENT N° 07554F30 (Filed With SEC on May 14, 2013)
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY and INNOGENE PHARMACEUTICALS, INC. PATENT LICENSE AGREEMENT (EXCLUSIVE) -1- (Filed With SEC on May 14, 2013)
